Remote Monitoring for Equity in Advancing Control of Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 540 participants.

Also called NCT05481892

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 540 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05481892
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05481892. Randomized; single masking; primary purpose health services research. Start 2023-04-20 (actual); primary completion 2026-04-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Remote Monitoring for Equity in Advancing Control of Hypertension
Acronym
REACH
Condition
Hypertension
Intervention (Device)
Cellular Home blood pressure (BP) monitoring
Lead sponsor
University of California, San Francisco (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05481892
Content hash
8dcf33460dfdf0d0f9140759aa7e975ee44268b673a411afd770cef561a4f818